Specifically, IGF2BP3 regulates the alternative splicing patterns of PKM genes, known for aberrant splicing in various cancers, potentially promoting lung tumourigenesis and offering a novel therapeutic target for patients with lung cancer.128. Here, IGF2BP3 is linked to lung carcinoma.